Latest filing published 10 Jan 2019 for Salarius Pharmaceuticals, Inc., €108k.
Filing timeline
BuySaleInsider track record
Boston Foundation, Inc.: trading record in brief
Boston Foundation, Inc. discloses dealings in Salarius Pharmaceuticals, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 8 January 2019 and the latest from 9 January 2019.
Sales make up the whole of the open-market record (2 sales, €199k).
On 10 January 2019 came the latest disclosure, an open-market sale for €108k in Salarius Pharmaceuticals, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Boston Foundation, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 337,000 shares@ US$0.367554.3% of flowCommon Stock, par value $0.0001SEC:0001762003-19-000002:0
- 263,000 shares@ US$0.396645.7% of flowCommon Stock, par value $0.0001SEC:0001762003-19-000001:0
2 of 2 declarations
